Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.94 USD | -1.52% | -11.82% | -49.35% |
05-02 | Acurx Pharmaceuticals, Inc. Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global Scientific Conference | CI |
04-04 | Top Premarket Gainers | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bearish | Neutral |
Resistance | 2.450 | 2.870 | 5.380 |
Spread/Res. | -20.82% | -32.40% | -63.94% |
Spread/Supp. | +18.65% | +18.65% | +29.33% |
Support | 1.635 | 1.635 | 1.500 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ACXP Stock
- Charts Acurx Pharmaceuticals, Inc.